Skip to main content
NEO logo

NEO · Neogenomics Inc · Webcasts, Transcripts & Audio

Track NEO — free
Market Cap
$1.98B
Shares
129.39M
Volume · Nov 19 37.05K Avg daily vol (3M) 1.96M

Neogenomics Inc Webcasts

Earnings calls, investor updates, investor days and conferences for Neogenomics Inc (NEO), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.

Conference
Investor event
2026-12-01
Neogenomics Inc (NEO) December 1, 2026 Conference
Scheduled
No reported result — non-financial event
Audio Transcript Slides
Conference
Investor event
2026-12-01
Neogenomics Inc (NEO) December 1, 2026 Conference
Scheduled
No reported result — non-financial event
Audio Transcript Slides
Conference
Investor event
2026-11-17
Neogenomics Inc (NEO) November 17, 2026 Conference
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY26 · Q3
2026-10-28
Neogenomics Inc (NEO) Q3 2026 Earnings Call Transcript
Confident tone NGS growth and portfolio mix MRD launch and reimbursement Margin expansion and operational excellence
Revenue
$209.25M
▲ 11.4% YoY
Gross margin
46.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Conference
Investor event
2026-09-15
Neogenomics Inc (NEO) September 15, 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY26 · Q2
2026-07-28
Neogenomics Inc (NEO) Q2 2026 Earnings Call Transcript
Positive tone Raised full-year guidance Clinical revenue and NGS growth Commercial reorganization
Revenue
$201.66M
▲ 11.2% YoY
Gross margin
45.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Conference
Investor event
2026-06-04
Neogenomics Inc (NEO) June 4, 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Annual General Meeting
Investor event
2026-05-21
Neogenomics Inc (NEO) May 21, 2026 Annual General Meeting Transcript
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY26 · Q1
2026-04-28
Neogenomics Inc (NEO) Q1 2026 Earnings Call Transcript
Confident tone NGS portfolio and PanTracer RaDaR ST MRD launch Pathline acquisition and lab network
Revenue
$186.67M
▲ 11.1% YoY
Gross margin
43.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Conference
Investor event
2026-03-10
Neogenomics Inc (NEO) March 10, 2026 Conference
No reported result — non-financial event
Audio Transcript Slides
Conference
Investor event
2026-03-03
Neogenomics Inc (NEO) March 3, 2026 Conference
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY25 · Q4
2026-02-17
Neogenomics Inc (NEO) Q4 2025 Earnings Call Transcript
Positive tone RADAR ST MRD launch Clinical business growth Pathline acquisition synergies
Revenue
$190.17M*
▲ 10.6% YoY
Gross margin
43.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Conference
Investor event
2026-01-13
Neogenomics Inc (NEO) January 13, 2026 Conference
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY25 · Q3
2025-10-28
Neogenomics Inc (NEO) Q3 2025 Earnings Call Transcript
Confident tone Clinical growth and NGS momentum MRD and RaDaR ST launch Pathline acquisition and Northeast expansion
Revenue
$187.80M
▲ 11.9% YoY
Gross margin
42.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-07-29
Neogenomics Inc (NEO) Q2 2025 Earnings Call Transcript
Positive tone NGS Growth and Mix PanTracer Liquid Biopsy Launch Pharma/Nonclinical Weakness
Revenue
$181.33M
▲ 10.2% YoY
Gross margin
42.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2025-04-29
Neogenomics Inc (NEO) Q1 2025 Earnings Call Transcript
Positive tone NGS growth and product launches Pathline acquisition and Northeast expansion Leadership transition and culture
Revenue
$168.03M
▲ 7.5% YoY
Gross margin
43.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2025-02-18
Neogenomics Inc (NEO) Q4 2024 Earnings Call Transcript
Confident tone Clinical/NGS Growth MRD Strategy and Partnerships Adjusted EBITDA and Margin Expansion
Revenue
$172.00M*
▲ 10.6% YoY
Gross margin
44.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q3
2024-11-05
Neogenomics Inc (NEO) Q3 2024 Earnings Call Transcript
Positive tone NGS as Growth Driver New Product Launches Pharma / Clinical Services Turnaround
Revenue
$167.82M
▲ 10.4% YoY
Gross margin
44.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q2
2024-07-29
Neogenomics Inc (NEO) Q2 2024 Earnings Call Transcript
Confident tone NGS and Advanced Diagnostics Innovation MRD Strategy and R&D Revenue Growth and Financial Performance
Revenue
$164.50M
▲ 12% YoY
Gross margin
44.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2024-04-30
Neogenomics Inc (NEO) Q1 2024 Earnings Call Transcript
Confident tone Clinical Services growth and NGS Commercial organization and sales force expansion Advanced Diagnostics / Pharma
Revenue
$156.24M
▲ 13.9% YoY
Gross margin
41.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2024-02-20
Neogenomics Inc (NEO) Q4 2023 Earnings Call Transcript
Confident tone Revenue and EBITDA Growth Clinical Services Performance NGS Volume and Mix Shift
Revenue
$155.55M*
▲ 12.1% YoY
Gross margin
43.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q3
2023-11-06
Neogenomics Inc (NEO) Q3 2023 Earnings Call Transcript
Revenue
$151.95M
▲ 18% YoY
Gross margin
41.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2023-08-08
Neogenomics Inc (NEO) Q2 2023 Earnings Call Transcript
Revenue
$146.92M
▲ 17.5% YoY
Gross margin
40.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2023-05-08
Neogenomics Inc (NEO) Q1 2023 Earnings Call Transcript
Revenue
$137.22M
▲ 17.1% YoY
Gross margin
39.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2023-02-23
Neogenomics Inc (NEO) Q4 2022 Earnings Call Transcript
Revenue
$138.71M*
▲ 10.3% YoY
Gross margin
41.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q3
2022-11-08
Neogenomics Inc (NEO) Q3 2022 Earnings Call Transcript
Revenue
$128.78M
▲ 6.1% YoY
Gross margin
38.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q2
2022-08-09
Neogenomics Inc (NEO) Q2 2022 Earnings Call Transcript
Revenue
$125.07M
▲ 2.8% YoY
Gross margin
35.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q1
2022-04-27
Neogenomics Inc (NEO) Q1 2022 Earnings Call Transcript
Revenue
$117.17M
▲ 1.4% YoY
Gross margin
32.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2022-02-23
Neogenomics Inc (NEO) Q4 2021 Earnings Call Transcript
Revenue
$125.73M*
▼ 0.2% YoY
Gross margin
36.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY21 · Q3
2021-11-04
Neogenomics Inc (NEO) Q3 2021 Earnings Call Transcript
Revenue
$121.34M
▼ 3.3% YoY
Gross margin
38.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q2
2021-08-06
Neogenomics Inc (NEO) Q2 2021 Earnings Call Transcript
Revenue
$121.72M
▲ 39.9% YoY
Gross margin
43.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q1
2021-05-05
Neogenomics Inc (NEO) Q1 2021 Earnings Call Transcript
Revenue
$115.53M
▲ 9% YoY
Gross margin
36.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q4
2021-02-24
Neogenomics Inc (NEO) Q4 2020 Earnings Call Transcript
Revenue
$126.00M*
▲ 17.9% YoY
Gross margin
45.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY20 · Q3
2020-10-27
Neogenomics Inc (NEO) Q3 2020 Earnings Call Transcript
Revenue
$125.44M
▲ 19.8% YoY
Gross margin
43.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q2
2020-07-28
Neogenomics Inc (NEO) Q2 2020 Earnings Call Transcript
Revenue
$86.98M
▼ 14.5% YoY
Gross margin
32.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q1
2020-04-09
Neogenomics Inc (NEO) Q1 2020 Earnings Call Transcript
Revenue
$106.03M
▲ 10.9% YoY
Gross margin
43.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY19 · Q4
2020-02-27
Neogenomics Inc (NEO) Q4 2019 Earnings Call
Revenue
$106.87M
▲ 39.7% YoY
Gross margin
46.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Showing 1–37 of 37 webcasts
Key facts CIK 1077183 CUSIP 64049M209 13F (30d) 301 filings 280 filers Visit website Investor relations